Microsomal triglyceride transfer protein (MTP) is needed to assemble chylomicrons in the endoplasmic reticulum (ER) of enterocytes. We explored the role of an ER stress protein, inositol-requiring enzyme 1b (IRE1b), in regulating this process. Highcholesterol and high-fat diets decreased intestinal IRE1b mRNA in wild-type mice. Ire1b À/À mice fed high-cholesterol and high-fat diets developed more pronounced hyperlipidemia because these mice secreted more chylomicrons and expressed more intestinal MTP, though not hepatic MTP, than wildtype mice did. Chylomicron secretion and MTP expression also were increased in primary enterocytes isolated from cholesterol-fed Ire1b À/À mice. There was no correlation between ER stress and MTP expression. Instead, cell culture studies revealed that IRE1b, but not its ubiquitous homolog IRE1a, decreased MTP mRNA through increased posttranscriptional degradation. Conversely, knockdown of IRE1b enhanced MTP expression. These studies show that IRE1b plays a role in regulating MTP and in chylomicron production.
INTRODUCTION
Chylomicrons are specialized vehicles synthesized by the intestine to transport large quantities of dietary fat and fat-soluble vitamins (Hussain et al., 1996; Hussain, 2000) . Increased absorption of lipids is associated with metabolic disorders such as obesity, atherosclerosis, and diabetes. Chylomicron biosynthesis depends on apolipoprotein B (apoB), a structural protein, and microsomal triglyceride transfer protein (MTP), an endoplasmic reticulum (ER)-resident chaperone (Hussain et al., 2003a (Hussain et al., , 2003b . MTP transfers several lipids and helps form primordial apoB lipoproteins (Hussain et al., 2003a (Hussain et al., , 2003b . The phospholipid transfer activity of MTP is sufficient for lipoprotein assembly. Evolutionarily, it is the oldest activity (Sellers et al., 2003; Rava et al., 2006; Rava and Hussain, 2007) .
The central role of the ER in chylomicron assembly prompted us to examine the inositol-requiring enzyme 1b (IRE1b) in the intestinal epithelial cells of vertebrates (Bertolotti et al., , 2001 Iwawaki et al., 2001) . IRE1b is closely related to the ubiquitously expressed ER stress-response protein IRE1a (Bernales et al., 2006) . IRE1 proteins anchored in the ER membrane contain a sensory domain that is exposed to the lumen and an effector domain facing the cytosol. The conserved effector domain of IRE1 is homologous to the viral-induced RNA-degrading enzyme RNase L. IRE1 proteins mediate the splicing of the X-box-binding protein 1 (XBP-1) mRNA precursor (Zhang et al., 2005; Niwa et al., 1999; Calfon et al., 2002) . The spliced mRNA is translated more efficiently, and the synthesized protein acts as a transcription factor for several genes involved in the unfolded protein response (Yoshida et al., 2001) . Although IRE1a acts mainly via XBP-1 splicing, there are exceptions. Glucose enhances IRE1a phosphorylation in pancreatic b cells and augments insulin biosynthesis without increasing XBP-1 splicing (Lipson et al., 2006) . In Drosophila, IRE1 can degrade specific mRNAs undergoing translation at the ER membrane and halt protein synthesis (Hollien and Weissman, 2006) . Ire1b À/À mice develop normally and are fertile, but they are resistant to toxin-induced colitis (Bertolotti et al., 2001) . In this study, we show that Ire1b À/À mice respond to cholesterol-rich and fat-rich diets with enhanced intestinal MTP expression and chylomicron production. (Napoli et al., 2003) . A high-cholesterol diet did not increase plasma levels of cholesterol and triglyceride in WT SV129 mice (Figures 1A and 1B, +/+) , which agrees with the results of Schwarz et al. (2001) . In contrast, because of a 2-to 4-fold increase in nonhigh-density lipoprotein (non-HDL) apoB lipoproteins (Figures 1C and 1D) , both of these diets significantly increased plasma levels of cholesterol ( Figure 1A ) and triglycerides ( Figure 1B ) in KO mice. HDL cholesterol and triglyceride levels were similar in WT and KO mice ( Figures 1E and 1F Figure 1K , +/+), as reported by Schwarz et al. (2001) . Similar increases were seen in KO mice ( Figure 1K , À/À). There were no significant differences in hepatic cholesterol and triglyceride levels in cholesterol-fed WT and KO mice (Figures 1K and 1L, hatched bars) . However, hepatic cholesterol and triglyceride levels were higher in KO mice than they were in WT mice fed a high-fat diet ( Figures 1K and 1L , black bars). KO mice accumulated less intestinal cholesterol and triglyceride on both diets compared with WT mice ( Figures 1M  and 1N ). Thus, on high-cholesterol and high-fat diets, Ire1b
mice show lower intestinal lipid accumulation than WT mice do.
Increases in plasma apoB lipoprotein levels and decreases in intestinal lipid levels could be explained by similar uptake in WT and KO mice and enhanced secretion of intestinal lipoproteins in KO mice. Long-term cholesterol absorption studies using a dual-label fecal excretion method failed to show any significant differences (see Figure S1 available online), indicating similar uptake. Next, we performed short-term absorption studies. Radioactive cholesterol and triolein (Figures 2A-2D ) were fed to cholesterol-fed WT and KO mice. After 2 hr, there was an approximately 50% increase in plasma [ 3 H]cholesterol of KO mice compared with WT mice because of a 3.5-fold increase in non-HDL apoB lipoproteins, with no change in HDL levels ( Figure 2A ). The KO mice also showed an approximately 30% increase in hepatic [ 3 H]cholesterol ( Figure 2B ). These studies show increased absorption of radiolabeled cholesterol by KO mice. Compared with WT mice, plasma [ 3 H]triolein-derived counts were approximately 60% higher in KO mice because of a 2-fold increase in non-HDL apoB lipoproteins ( Figure 2C ), but hepatic [ 3 H]triolein counts were similar in these mice ( Figure 2D ). These observations are consistent with the understanding that absorbed dietary cholesterol and fatty acids are primarily delivered to the liver and the peripheral tissues, respectively. These results suggest that IRE1b deficiency increases lipid absorption via apoB lipoproteins. To confirm increased lipid absorption in KO mice, mice fed high-cholesterol diets were injected intraperitoneally with the lipoprotein lipase inhibitor poloxamer 407 (Millar et al., 2005; Anwar et al., 2007) Figure 2E ). These counts were 20 times higher in poloxamer 407-injected animals than those seen in mice not injected with the lipase inhibitor (compare to Figure 2A ), indicating significant inhibition of lipoprotein clearance. Gel filtration analysis showed increased counts in the apoB lipoproteins (VLDL/CM) of KO mice ( Figure 2F ). Mass measurements showed that total plasma cholesterol and triglyceride levels were greater in apoB lipoproteins ( Figures 2G-2J ). These studies indicate increased lipid absorption via apoB lipoprotein production in Ire1b À/À mice. Despite the decreased intestinal cholesterol level in KO mice ( Figures 1M and 1N ), isolated primary enterocytes showed no differences in the uptake of radiolabeled cholesterol ( Figure 2K ), and NPC1L1 mRNA levels were similar in WT and or for density gradient ultracentrifugation. Fractions were collected from the top and assayed for radioactivity (N). Each measurement was performed in triplicate with n = 3 mice per group. Values are mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001 versus Ire1b +/+ . KO mice (Figures S2A and S2C) . However, cholesterol secretion was higher in KO enterocytes ( Figure 2L ). Therefore, KO enterocytes take up cholesterol as efficiently as WT enterocytes but secrete more cholesterol than WT, explaining the lower levels of intestinal cholesterol in KO mice. Figure 2M ), which could reflect a more substantial increase in chylomicrons with no increase in other lipoproteins. Therefore, we subjected the conditioned media to potassium bromide density gradient ultracentrifugation to separate chylomicrons from other lipoproteins. The WT enterocytes secreted
Primary Enterocytes from Cholesterol-Fed Ire1b
into chylomicrons at the top of the gradient (Luchoomun and Hussain, 1999) and into HDL particles at the bottom of the gradient , consistent with the secretion of cholesterol via both apoB-dependent and apoB-independent pathways Iqbal et al., 2003; Hussain et al., 2005) . The secretion of [ 3 H]cholesterol into chylomicronlike particles was approximately 3.7-fold greater in KO versus WT enterocytes ( Figure 2N , fraction 1), while secretion into HDL lipoproteins was similar ( Figure 2N , fractions 8-10). Thus, IRE1b deficiency selectively increases chylomicron secretion.
Intestinal MTP mRNA and Activity Are Elevated in Cholesterol-and Fat-Fed Ire1b À/À Mice MTP is an essential chaperone and a rate-limiting factor for chylomicron assembly (Hussain et al., 2003a (Hussain et al., , 2003b 
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Regulation of MTP by IRE1b and 3J), but there were no differences in apoB (Figures 3C and 3K) or GAPDH ( Figures 3D and 3L ) mRNA. Hepatic MTP mRNA levels were similar in KO and WT mice ( Figures 3F and 3N ), as were levels of apoB and GAPDH ( Figures 3G, 3H , 3O, and 3P). MTP activity and mRNA levels were not changed in chow-fed KO or WT mice, and we did not find differences between cholesterol-fed KO and WT animals in the intestinal and hepatic mRNA levels of several ER proteins involved in lipid metabolism and ER stress responses ( Figures S2A-S2D ). Thus, IRE1b deficiency in cholesterol-fed and fat-fed mice leads to a selective increase in intestinal MTP.
To test whether increases in MTP lead to increased apoB lipoprotein secretion, we transfected COS cells, which do not express apoB or MTP, with an apoB48 expression plasmid and different amounts of a human MTP-FLAG expression plasmid ( Figure S4 ). No apoB was secreted in the absence of MTP, but apoB secretion increased as MTP expression increased, consistent with other studies Leiper et al., 1994) .
Changes in MTP Expression Are Not Correlated with ER Stress
We next sought to identify how IRE1b deficiency leads to increased MTP. Although IRE1b-mediated XBP-1 mRNA splicing in cholesterol-fed WT mice could theoretically suppress MTP mRNA, intestinal samples from chow-fed and cholesterol-fed animals did not induce XBP-1 mRNA splicing ( Figure 4A ) or IRE1a, BiP, or CHOP mRNA levels, which increase during ER stress ( Figures 4B-4D) . To increase sensitivity, we used enterocytes isolated from cholesterol-fed WT and KO mice and found an increase in MTP mRNA levels but no changes in IRE1a, BiP, or CHOP ( Figure 4E ) or in XBP-1 mRNA splicing ( Figure 4F ). As a control, XBP-1 mRNA splicing was evident in tunicamycin-exposed human hepatoma Huh7 cells ( Figure 4F ). These data indicate that a high-cholesterol diet does not induce intestinal ER stress. In contrast, the high-fat diet induced similar levels of ER stress in the intestines of both WT and KO mice, as evidenced by XBP-1 mRNA splicing ( Figure 4A ), and increases in IRE1a, BiP, and CHOP mRNA (Figures 4B-4D) . Thus, induction of ER stress is independent of genotype and is a consequence of a high-fat diet.
In WT mice, a high-fat diet increased intestinal MTP mRNA by 68% ( Figure 4G , +/+). High-cholesterol diet and high-fat diet increased intestinal MTP mRNA in KO mice 2-fold and 3-fold ( Figure 4G , À/À), respectively, compared with chow-fed WT. The high-cholesterol and high-fat diets decreased IRE1b mRNA levels by 33% and 59%, respectively, in WT mice ( Figure 4H , +/+). Thus, both diets reduce intestinal IRE1b in WT mice but increase MTP mRNA in Ire1b À/À mice. Direct cell stress and activation of XBP-1 splicing in Caco-2 human colon carcinoma cells ( Figure 4I ) and primary enterocytes ( Figure 4J ) by tunicamycin or thapsigargin did not affect MTP mRNA ( Figures 4K and 4L ) or activity (data not shown) but did increase IRE1a, BiP, and CHOP mRNA levels. In summary, a high-cholesterol diet does not induce ER stress but increases intestinal MTP mRNA in KO mice. A high-fat diet induces similar ER stress in both WT and KO mice but significantly induces MTP mRNA only in the intestines of KO mice. Furthermore, induction of ER stress and XBP-1 in intestinal cells does not affect MTP expression.
MTP mRNA Changes Proportionally to IRE1b Expression
To test whether MTP is directly suppressed by IRE1b, we transfected human hepatoma Huh7 cells, which express MTP but not IRE1b, with c-Myc-tagged plasmids expressing full-length IRE1b (IRE1b-WT) and C-terminally truncated IRE1b (IRE1b-DC) lacking the kinase and endoribonuclease domains ( Figure 5A ) (Urano et al., 2000; Wang et al., 1998) . Expression of IRE1b-DC did not affect MTP mRNA ( Figure 5C ), apoB secretion ( Figure 5D ), or protein disulfide isomerase (PDI) mRNA ( Figure 5E ). IRE1b-WT expression reduced 28S rRNA ( Figure 5B ) consistent with Iwawaki et al. (2001) , suppressed MTP mRNA ( Figure 5C ), and decreased apoB lipoprotein secretion ( Figure 5D ) but did not affect PDI ( Figure 5E ) or apoB, apoAI, ACAT1, ACAT2, MGAT2, MGAT3, DGAT1, DGAT2, or NPC1L1 mRNA ( Figure S2E ), suggesting no general effects on cell health.
We next determined the consequences of decreasing IRE1b on MTP expression in undifferentiated Caco-2 cells through RNA interference. IRE1b siRNA reduced its target mRNA by 60% with no effect on IRE1a mRNA ( Figure 5F ). More importantly, IRE1b knockdown increased MTP mRNA by 50% ( Figure 5F ) and did not affect PDI mRNA. These data show that expression and suppression of IRE1b lead to specific changes in MTP mRNA through a mechanism that requires the kinase and ribonuclease domains.
To investigate why cholesterol feeding was necessary to observe differences in plasma lipid levels in WT and KO mice, Huh7 cells were transfected with IRE1b-WT or IRE1b-DC and cultured in the presence or absence of cholesterol. Cholesterol treatment of cells expressing IRE1b-DC significantly increased MTP mRNA ( Figure 5G ) and activity ( Figure 5H ), as occurred in KO mice fed a high-cholesterol diet ( Figures 3A and 3B ). In contrast, cholesterol supplementation of cells expressing IRE1b-WT did not affect MTP mRNA ( Figure 5G ) or activity ( Figure 5H ). Therefore, IRE1b counteracts cholesterol-induced increases in MTP expression. Similar studies were not performed with high fatty acid concentrations because they are toxic to cells.
Next, we asked whether overexpression of IRE1b in Huh7 cells increases ER stress and decreases MTP mRNA. Expression of IRE1b-DC and IRE1b-WT had no effect on IRE1a, BiP, or CHOP mRNA ( Figure 5I ), and no splicing of XBP-1 occurred in these cells ( Figure 5J ). On the other hand, treatment of Huh7 cells with tunicamycin increased ER stress indicators, IRE1a, BiP, CHOP, and XBP-1 splicing ( Figures 5I and 5J) . Thus, Huh7 cells respond to ER stress transducers but do not upregulate these genes when transfected with IRE1b. We conclude that IRE1b decreases MTP levels without inducing an ER stress response.
IRE1b Decreases MTP mRNA by Promoting Posttranscriptional Degradation
To determine whether IRE1b-mediated suppression of MTP mRNA occurs at the transcriptional level, we determined the promoter activity of a 1.5 kb sequence upstream of the transcription initiation site. Luciferase activity expressed under the control of the MTP (mttp) promoter could be measured in Huh7 and Caco-2 cells but not HEK293 cells ( Figure 6A ), indicating that the promoter is sufficient for expression in the intestine and liver; this is consistent with other studies showing that 204 bases are sufficient for MTP expression (Hagan et al., 1994; Hirokane et al., 2004; Kang et al., 2003) . To evaluate whether IRE1b affects mttp promoter activity, we cotransfected Huh7 cells with a plasmid expressing luciferase under the control of the 1.5 kb mttp promoter as well as pcDNA3.1, IRE1b-WT, or IRE1b-DC expression plasmids. IRE1b-WT did not suppress mttp promoter activity compared with vector control or IRE1b-DC ( Figure 6B ), indicating that IRE1b does not reduce MTP levels by altering mttp promoter activity.
To explore posttranscriptional mechanisms, we used mouse fibroblast L cells stably transfected with mouse MTP cDNA under the control of the cytomegalovirus promoter (Dougan et al., 2007) . Expression of IRE1b-WT in these cells reduced endogenous MTP mRNA ( Figure 6C ), activity ( Figure 6D ), and protein ( Figure 6D inset) . In contrast, IRE1b-DC and IRE1a had no effect on MTP mRNA ( Figure 6C ), activity ( Figure 6D ), or protein ( Figure 6D inset) . To explore whether IRE1b decreases the stability of MTP mRNA, Huh7 cells expressing IRE1b-WT or IRE1b-DC were treated with actinomycin D to block new mRNA transcription. MTP mRNA, but not PDI mRNA, decayed at a greater rate in cells expressing IRE1b-WT than in cells expressing IRE1b-DC ( Figure 6E ), indicating that IRE1b-WT promotes MTP mRNA degradation.
A plausible scenario for MTP mRNA degradation would involve its cleavage by IRE1b endonuclease activity (Figure 6F) , followed by exonuclease digestion of the cleaved products. In this context, the exonucleases Ski2 and XRN1/2 may perform 3 0 /5 0 and 5 0 /3 0 exonuclease digestion, respectively, of endonuclease-cleaved mRNA (Newbury, 2006; Houseley et al., 2006; Meyer et al., 2004) . Thus, knockdown of these exonucleases should preserve the putative 5 0 or 3 0 cleavage products of MTP mRNA. To test this, Huh7 cells were transfected with IRE1b-WT or IRE1b-DC and treated with Ski2, XRN1, XRN2, or control GL2 siRNA, which specifically reduced 70%-75% of the target mRNAs ( Figure 6G ). Expression of IRE1b-WT decreased MTP mRNA sequences corresponding to exons 1-2 (5 0 ) and exons 7-8 (3 0 ) when treated with control GL2 siRNA but did not affect PDI mRNA levels ( Figure 6H , WT+GL2). Treatment with Ski2 siRNA prevented the loss of sequences corresponding to MTP exons 1-2 but not exons 7-8 ( Figure 6H, WT+Ski2) . Similarly, XRN1 and XRN2 siRNA selectively limited the loss of exons 7-8. These data are consistent with IRE1b-dependent endonuclease cleavage between exons 2 and 7, followed by 3 0 /5 0 exonuclease cleavage of the 5 0 fragment(s) by Ski2 and 5 0 /3 0 exonuclease cleavage of the 3 0 fragment(s) by XRN1 and XRN2.
DISCUSSION
IRE1b deficiency in mice enhances intestinal MTP expression without affecting hepatic MTP and increases lipid absorption and chylomicron secretion in response to high-cholesterol and high-fat diets. IRE1b reduces MTP mRNA levels by augmenting posttranscriptional degradation. Thus, the present study identifies an intestine-specific mechanism controlling the assembly and secretion of apoB lipoproteins, wherein IRE1b regulates chylomicron production by degrading MTP mRNA. Eating high-cholesterol and high-fat diets enhances MTP expression in the liver, and to a lesser extent in the intestine, of WT mice. In contrast, diet-induced increases in intestinal and hepatic MTP are similar in KO mice. These observations indicate that MTP expression is more responsive to dietary manipulations in the absence of IRE1b and that IRE1b blocks diet-induced upregulation of intestinal MTP in WT mice.
Ire1b À/À mice fed high-cholesterol or high-fat diets produce more intestinal apoB lipoproteins both in vivo (Figures 2A-2J ) and in isolated enterocytes ( Figures 2M and 2N ), which eliminates generalized intestinal damage, permeability, and other pathological mechanisms as potential explanations for this increase. This increased apoB lipoprotein production is probably secondary to increased MTP activity because (1) IRE1b deficiency did not affect apoB mRNA, (2) changes in MTP (G) Huh7 cells were transfected with IRE1b-WT. After 24 hr, cells were transfected with siRNAs against Ski2, XRN1, or XRN2. RNA was isolated after 48 hr and used to quantify Ski2, XRN1, or XRN2 mRNA in control (siGL2) and RNAi-treated cells to determine the efficacy and specificity of RNA interference.
(H) Huh7 cells were transfected in triplicate with IRE1b-DC or IRE1b-WT expression plasmids. After 24 hr, cells were transfected with indicated siRNAs. Total RNA from these cells was used to amplify different regions (exons 1-2 and exons 7-8) of MTP mRNA using primers listed in Table S1 . Data are representative of two experiments performed in triplicate. Values are mean ± SD.
expression significantly altered the secretion of apoB lipoproteins ( Figure S4 ), and (3) changes in MTP levels affect plasma lipid and apoB lipoprotein levels (Tietge et al., 1999; Ameen et al., 2005; Wolfrum and Stoffel, 2006; Lin et al., 1994) . Conversely, repression of MTP was associated with decreased apoB secretion. Chenodeoxycholate reduces MTP expression and apoB secretion in HepG2 cells (Hirokane et al., 2004) . MTP antagonists reduce plasma lipids (Cuchel et al., 2007; Wetterau et al., 1998) . Thus, changes in MTP activity significantly affect plasma apoB lipoprotein levels. Therefore, increases in MTP due to IRE1b deficiency are sufficient to augment apoB lipoprotein production. mttp À/À mice are not viable (Raabe et al., 1998 (Raabe et al., 1998) . Halfnormal MTP levels reduce apoB lipoprotein secretion to a similar extent in apob +/À and apoB transgenic mice (Leung et al., 2000) . Therefore, MTP deficiency reduces apoB lipoprotein production and decreases plasma cholesterol when challenged with a highfat diet. In Ire1b À/À mice, increases in intestinal MTP increase apoB lipoprotein production and enhance plasma cholesterol levels.
In abetalipoproteinemia, MTP deficiency significantly reduces total and LDL cholesterol. In general, obligate MTTP heterozygotes present with normal plasma cholesterol, but several parents of abetalipoproteinemia patients have been found to have low cholesterol (Raabe et al., 1998; Narcisi et al., 1995; Berriot-Varoqueaux et al., 2000; Di Leo et al., 2005) . The variations in plasma cholesterol in heterozygotes might result from an adaptation involving increased synthesis of MTP by the normal allele (Berriot-Varoqueaux et al., 2000) . Moreover, plasma apoB lipoproteins have not been characterized, and high-fat feeding studies have not been performed in heterozygotes. Therefore, there are insufficient data to draw conclusions about the effect of half-normal MTP levels on plasma apoB lipoproteins.
Although IRE1 functions primarily via splicing XBP-1 mRNA, it represses ER-targeted mRNA independently of the XBP-1 pathway (Hollien and Weissman, 2006) . IRE1b may reduce protein synthesis by cleaving 28S ribosomal RNA (Iwawaki et al., 2001) . IRE1a regulates proinsulin synthesis without enhancing XBP-1 splicing (Lipson et al., 2006) . We did not observe spliced XBP-1 mRNA in the intestines of cholesterol-fed WT mice, and induction of XBP-1 splicing by tunicamycin and thapsigargin did not alter MTP mRNA levels (Figure 4) . Thus, intestinal IRE1b regulates MTP independently of the XBP-1 pathway.
Despite the sequence homology between IRE1a and IRE1b, the effect on MTP mRNA regulation was specific to IRE1b ( Figure 6C ). The cytosolic domains that contain the kinase and endoribonuclease activities in mouse IRE1b and IRE1a exhibit 62%-63% identity, but the identity of the luminal domains is only 41%. Therefore, IRE1b may have evolved to detect a specific luminal signal-for example, fat status.
The posttranscriptional degradation of MTP mRNA could involve direct endolytic cleavage. IRE1b and MTP mRNA translation are associated with the ER membrane, and overexpression of MTP may therefore facilitate its degradation by IRE1b. Alternatively, increased chylomicron assembly may temporarily stall the protein translational machinery, leading to the recognition of the MTP mRNA by IRE1b directly or via recruitment/activation of another endonuclease. If so, all components are present in the liver, and IRE1b may be the limiting factor for MTP downregulation.
We can only speculate as to why the enterocytes of vertebrates have this regulatory pathway to control chylomicron assembly. One hypothesis is that enterocytes optimize fat absorption by activating the ER stress response and downregulating IRE1b. By upregulating the ER stress response, the ER is protected from the increased load of synthesizing and packaging chylomicrons. By downregulating IRE1b, chylomicron assembly is maximized by enhancing MTP. In the fasting state, it may be beneficial to limit chylomicron secretion by degrading MTP mRNA to conserve critical cellular lipids and fat-soluble vitamins and to avoid rapid fluctuations in membrane phospholipids, neutral lipids, and vitamin E. Alternatively, IRE1b may mediate downregulation of chylomicron secretion in response to satiety signals or respond to endocrine factors from the liver and adipose tissue under conditions of excess whole-body lipid accumulation. In the absence of IRE1b, this postprandial mechanism of optimizing fat absorption is derailed, leading to a sustained hyperlipidemia.
In summary, these studies highlight an intestine-specific mechanism controlling lipid absorption. In this mechanism, IRE1b regulates MTP mRNA levels involving posttranscriptional degradation. IRE1b restricts MTP induction in the intestine by high-fat and high-cholesterol diets. These findings raise the possibility that upregulation of IRE1b may be beneficial in avoiding diet-induced hyperlipidemia. 
EXPERIMENTAL PROCEDURES

Materials
Animals and Diets
Ire1b À/À (KO) and Ire1b +/+ (WT) mice on an SV129 background were used (Bertolotti et al., 2001) . To study the effects of a high-cholesterol diet, 10-to 16-week-old male mice were fed a chow diet containing 2% w/w cholesterol for 14 days, with no significant effect on body weight. Histologic analyses revealed no overt differences in epithelial cell morphology or crypt cell mitotic figures. To study the effects of a high-fat diet, male WT and KO mice were fed a high-fat western diet containing 17%, 48.5%, 21.2%, and 0.2% by weight of protein, carbohydrate, fat, and cholesterol, respectively (TD88137, Harlan Teklad). Food was withdrawn the night before the experiments.
Plasma Lipid Measurements
Total cholesterol and triglyceride levels were measured using kits (Thermo Trace Ltd.). HDL lipid levels were measured after precipitating apoB lipoproteins . Lipid levels in apoB lipoproteins were determined by subtracting HDL lipid levels from total lipid levels. Plasma lipoproteins were separated by gel filtration (flow rate of 0.2 ml/min) using a Superose 6 column, and 200 ml fractions were collected.
Short-Term Lipid Absorption Studies
Age-matched male mice (n = 3 per group) fed a high-cholesterol diet for 2 weeks were fasted overnight and gavaged with 1 mCi of either (Iqbal et al., 2003; Iqbal and Hussain, 2005) were suspended in 4 ml of DMEM containing 1 mCi/ml of [ 3 H]cholesterol and incubated at 37 C. Enterocytes were incubated for 1 hr with micelles containing 1.2 mM oleic acid (Iqbal et al., 2003; Iqbal and Hussain, 2005) . After 2 hr, enterocytes were centrifuged and supernatants were subjected to density gradient ultracentrifugation. Fractions were collected and radioactivity was counted. Cell pellets were incubated overnight at 4 C with 1 ml isopropanol to extract lipids. After extraction, proteins were dissolved in 1 ml of 0.1 N NaOH and quantified using Coomassie reagent (Pierce Chemical Company).
Determination of MTP Activity
Small pieces (0.1 g) of liver and proximal small intestine ($1 cm) were homogenized in low-salt buffer and centrifuged, and supernatants were used for protein determination and MTP assay (Athar et al., 2004; Rava et al., 2005) using a kit (Chylos Inc.).
RNA Isolation and Two-
Step Quantitative RT-PCR Total RNA from tissues and cells was isolated using TRIzol (Invitrogen). Purity and integrity were assessed by the A 260 /A 280 ratio and 1% agarose gel electrophoresis, respectively. RNAs with ratios greater than 1.7 were used for cDNA synthesis. The first-strand cDNA was synthesized with an Omniscript RT kit (QIAGEN) and used for quantitative RT-PCR (qPCR Core Kit for SYBR Green I, Eurogentec). Data were analyzed using the DDC T method and are presented as arbitrary units. The primers used were designed using PrimerExpress 3.0 (Applied Biosystems) and are listed in Table S1 . A two-step RT-PCR method was used to determine XBP-1 RNA splicing. The primers (Table S1 ) were designed to differentiate the two forms of XBP-1, which differ by 26 nucleotides. The PCR products were separated by 3% agarose or 12% polyacrylamide gels.
Plasmid Expression
The expression plasmids pIRE1b-WT and pIRE1b-DC have been described previously (Urano et al., 2000) . Plasmid pMTP1483 was generated by cloning a 1.4 kb mttp promoter into a pGL2 basic vector. Huh7 cells with endogenous MTP and mouse fibroblast L cells expressing mouse MTP under the control of the cytomegalovirus promoter (Dougan et al., 2007) were plated in 100 mm dishes. ExGen 500 (Fermentas) and PolyFect (QIAGEN) were used to transfect cells. After 24-48 hr transfection, cells were used to measure MTP protein and activity (Athar et al., 2004; Rava et al., 2005) as well for RNA extraction.
Small RNA Interference Huh7 cells transfected with IRE1b-WT or IRE1b-DC plasmids for 8 hr were transfected with siRNA against the exoribonucleases Ski2, XRN1, and XRN2 or control siGL2 by the siPORT NeoFX agent (Ambion). After 48 hr, RNA was extracted and used for quantitative RT-PCR.
Western Blot Analyses
Tissue and cell samples were homogenized in PBS containing 1% Triton X-100. Proteins (40 mg) were resolved on 4%-20% gradient gels (Bio-Rad). A monoclonal MTP antibody (BD Biosciences), rabbit anti-PDI (Santa Cruz), and mouse anti-GAPDH (Santa Cruz) were used to detect endogenous proteins. Overexpressed tagged mouse IRE1b proteins were detected using anti-c-Myc (9E10, Santa Cruz) antibodies. Secreted apoB was immunoprecipitated with goat anti-human apoB100 antibody and immunoblotted with 1D1 monoclonal antibody (Academy Bio-Medical Company, Inc.). MTP-FLAG was detected using anti-FLAG (Sigma) antibody. The resulting blots were developed using an ECL kit (Amersham). To quantify mass, in some western blots, we used Alexa Fluor 633 (Invitrogen) anti-mouse or anti-rabbit secondary antibodies and evaluated the blots using Storm 860 (Amersham). Bands were quantified using Scion Image (Scion Corporation).
Statistics
Data are presented as mean ± SD. Unless noted otherwise, n = 3 for each group or condition. Statistical significance (p < 0.05) was determined using Student's t test (GraphPad Prism).
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